Skip to main content
. 2023 Sep 7;23:302. doi: 10.1186/s12871-023-02262-2

Table 2.

Comparisons of outcomes between preconditioning group and control group

Outcomes Preconditioning group(n = 92) Control group
(n = 90)
P-value
Major outcomes
ED, N (%) 0.004
Negative 77(83.7) 58(64.4)
Positive 15(16.3) 32(35.6)
Degree of ED, N (%) 0.449
Mild 12(80.0) 23(71.9)
Moderate 2(13.3) 7 (21.9)
Severe 1(6.67) 2(6.25)
Intraoperative measurements
Duration of surgery, min 45.0(30.0, 68.8) 40.0(30.0, 60.0) 0.225
Duration of anesthesia, min 68.0(50.0, 88.0) 60.0(50.0, 79.3) 0.161
Intraoperative sufentanil dosage, µg 20.0(15.0, 20.0) 15(15.0, 20.0) 0.028
Dosage of sufentanil per unit anesthesia time, µg/min 0.27(0.27, 0.36) 0.27(0.22, 0.36) 0.562
FESS with septoplasty, N (%) 0.645
Without 82(89.1) 78(86.7)
With 10(10.9) 12(13.3)
Nasal package, N (%) > 0.999
Negative 25(27.2) 24(26.7)
Positive 67(72.8) 66(73.3)
Package Side, N (%) 0.666
Single 13(25.0) 16(29.6)
Both 39(75.0) 38(70.4)
Postoperative measurements
Medication in PACU, N/P 0.619
Negative 91(98.9) 88(97.8)
Positive 1(1.09) 2(2.22)
Time to extubation, min 16.0(12.0, 17.8) 17.0(12.0, 20.0) 0.714
PACU time, min 55.0(47.0,59.0) 56.0(47.0,59.0) 0.689
NRS in PACU 0(0, 6.00) 0(0, 6.00) 0.949
 h when left PACU, bpm 71.0 (64.0, 77.5) 71.0(61.0, 78.0) 0.689
MAP when left PACU, mmHg 84.0(80.0, 91.5) 86.5 (79.0, 94.0) 0.815
SpO2 when left PACU, % 99.0(98.0, 99.0) 99.0(98.0, 99.0) 0.235
Postoperative hospital stays, day 3.00(3.00, 4.00) 4.00(3.00, 4.00) 0.308

Note: Data were presented as median (IQR) or number (percentage). ED: emergence delirium; PACU: post-anesthesia care unit; NRS: numerical rating scale; HR: heart rate; MAP: mean arterial pressure; SpO2: oxygen saturation. A P-value < 0.05 indicates significant difference between the two groups